Armata Pharmaceuticals Inc. sell Lokrim
Start price
09.07.23
/
20%
€1.02
Target price
09.07.24
-
Performance (%)
123.53%
End price
11.12.23
€2.28
Summary
This prediction ended on 11.12.23 with a price of €2.28. The price for Armata Pharmaceuticals Inc. massively increased, which is bad news for the SELL prediction by Lokrim. Lokrim has 20% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Armata Pharmaceuticals Inc. | 4.444% | 4.444% | - |
| iShares Core DAX® | 3,02 % | 2,20 % | 14,66 % |
| iShares Nasdaq 100 | 3,56 % | 1,33 % | 31,41 % |
| iShares Nikkei 225® | 6,62 % | 5,71 % | 49,42 % |
| iShares S&P 500 | 2,64 % | 1,01 % | 25,12 % |
According to Lokrim what are the pros and cons of Armata Pharmaceuticals Inc. for the foreseeable future?
Pros
Cons
Revenue decline/stagnation expected
Risky Investment
Comments by Lokrim for this prediction
In the thread Armata Pharmaceuticals Inc. diskutieren
Sell Armata Pharmaceuticals Inc.
In the thread Trading Armata Pharmaceuticals Inc.
Sell beendet
Stopped prediction by Lokrim for Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€2.22
17.08.24
17.08.24
-
17.08.25
17.08.25
-6.31%
18.08.25
18.08.25
Revenue decline/stagnation expected
Risky Investment

